Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Midi Health provides virtual care for women in midlife, offering clinician support for menopause, hormonal health, and related conditions.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Myome helps identify genes that cause disease and act based on leading science.
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Thyme Care is a healthcare company that provides oncology care management services.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Sollis Health offers concierge medical centers that provide on-demand care for families, including same-day visits and virtual care options.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Foresite Capital has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 19 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. Foresite Capital's total known invested capital is $15.2B.
Foresite Capital's average investment size is $143.0M across its portfolio of 129 companies.
Recent Foresite Capital portfolio additions include Midi Health, Vaxcyte, bit.bio, Alumis, Aeovian Pharmaceuticals. These companies were founded in 2020 or later.